Top Life Sciences News Stories: Merck’s $3.8B deal for Idenix and Others | PharmaBoardroom
written on 13.06.2014
Tags:
,

Top Life Sciences News Stories: Merck’s $3.8B deal for Idenix and Others

TAGS: ,

The latest life sciences news stories and tweets from the week (June 9-13, 2014) are ready to view now. #AADPAC splits vote: 7 vote yes for CVOT across mu opioid class, 5 vote yes for specific drugs; 12 vote no — BioWorld Today (@BioWorld) June 12, 2014 AstraZeneca acquires global rights to Synairgen’s SNG-001 in […]

Latest Report